Sudarshan Chemical Industries Limited announced the approval of its Unaudited Financial Results for the quarter and nine months ended December 31, 2025, on February 12, 2026. The Board also sanctioned the renewal of a EURO 6 Million Corporate Guarantee for its subsidiary, Sudarshan Europe B.V. The standalone net profit for the quarter stood at ₹22.5 Crore, while the consolidated entity reported a net loss of ₹116.0 Crore for the quarter.
Board Meeting Outcomes: February 12, 2026
The Board of Directors of Sudarshan Chemical Industries Limited convened on Thursday, February 12, 2026, to transact several key businesses. The primary outcomes included the approval of the Unaudited Financial Results and the renewal of a significant corporate guarantee.
Unaudited Financial Performance (Q3 FY26)
Standalone Results
The Company approved the Unaudited Financial Results (Standalone) for the quarter ended December 31, 2025, along with the Limited Review Report from M/s. SRBC & CO LLP.
Key standalone figures for the quarter ended 31.12.2025 include:
- Revenue from operations: ₹550.3 Crore
- Profit for the period / year: ₹22.5 Crore
- Earnings per share (after exceptional items): ₹2.9
Consolidated Results
The consolidated results reflected a significant impact, largely due to exceptional items and business combination adjustments related to the Heubach acquisition.
Key consolidated figures for the quarter ended 31.12.2025 include:
- Total income: ₹2,117.2 Crore
- (Loss) / Profit for the period / year: (₹116.0 Crore) (Loss)
- Exceptional items expense: (₹45.4 Crore)
- Earnings per share (after exceptional items): (₹14.7) (Loss)
Corporate Guarantee Renewal
The Board approved the renewal of a Corporate Guarantee in favor of The Hongkong and Shanghai Banking Corporation Limited. This guarantee is on behalf of Sudarshan Europe B.V., a Wholly Owned Subsidiary.
The maximum amount guaranteed is EURO 6 Million, intended to secure the Revolving Credit Facility (Working Capital) for Sudarshan Europe B.V. This guarantee will be disclosed as a contingent liability in the standalone financial statements of the listed entity.
Segment Reporting Highlights (Consolidated)
The Segmental reporting shows the contrasting performance between the core Pigments business and the ‘Others’ segment for the quarter ended 31.12.2025 (All figures in ₹ Crore):
- Pigments Segment Revenue: ₹2,052.2 Crore (compared to ₹2,327.0 Crore in the previous quarter).
- Pigments Segment EBITDA: ₹39.8 Crore.
- Others Segment Revenue: ₹51.7 Crore.
- Others Segment EBITDA: (₹1.1 Crore) (Loss).
Trading Window Update
The trading window for dealing in the Company’s securities is set to reopen on Sunday, February 15, 2026, which is forty-eight hours after the declaration of the financial results.
Source: BSE
